Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
BP drug recalled | Tracking the cardiologist shortage | 'We will miss him greatly' | $36M for new IVL tech
Friday, January 31, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Blood pressure drug recalled due to black contaminants—FDA highlights safety risks

The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Blood pressure drug recalled due to black contaminants—FDA highlights safety risks

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death. 
READ MORE >

The US physician shortage shows no signs of stopping—what can cardiology leaders do?

The physician shortage that U.S. hospitals and health systems have been dreading is here—and its impact on cardiology could be quite significant.

READ MORE >
doctors nurses ai in healthcare fda oversight
Share on Twitter Share on Facebook Share on Linkedin

The US physician shortage shows no signs of stopping—what can cardiology leaders do?

Share on Twitter Share on Facebook Share on Linkedin
doctors nurses ai in healthcare fda oversight
The physician shortage that U.S. hospitals and health systems have been dreading is here—and its impact on cardiology could be quite significant.
READ MORE >

‘We will miss him greatly’: Cardiologists share loving tributes to a founding member of SCAI

Frank J. Hildner, MD, is remembered by colleagues for his significant contributions to the field of interventional cardiology as well as his positivity, warmth and generosity. 

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

‘We will miss him greatly’: Cardiologists share loving tributes to a founding member of SCAI

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
Frank J. Hildner, MD, is remembered by colleagues for his significant contributions to the field of interventional cardiology as well as his positivity, warmth and generosity. 
READ MORE >

Medical device company raises $36M for emitter-free IVL platform

Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

READ MORE >
AVS Pulse IVL
Share on Twitter Share on Facebook Share on Linkedin

Medical device company raises $36M for emitter-free IVL platform

Share on Twitter Share on Facebook Share on Linkedin
AVS Pulse IVL
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.
READ MORE >

Featured Articles

Cardiologist-founded startup raises $2M in the name of women’s heart health

Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist-founded startup raises $2M in the name of women’s heart health

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.
READ MORE >

TAVR valve improvements may have helped reduce the impact of paravalvular leak

Multiple studies over the years have linked PVL to an increased risk of adverse outcomes. New research out of Italy, however, suggests that device improvements made by Medtronic, Edwards Lifesciences and Boston Scientific may have reduced PVL's influence.

READ MORE >
Medtronic's Evolut Pro TAVR valve is designed to treat aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

TAVR valve improvements may have helped reduce the impact of paravalvular leak

Share on Twitter Share on Facebook Share on Linkedin
Medtronic's Evolut Pro TAVR valve is designed to treat aortic stenosis.
Multiple studies over the years have linked PVL to an increased risk of adverse outcomes. New research out of Italy, however, suggests that device improvements made by Medtronic, Edwards Lifesciences and Boston Scientific may have reduced PVL's influence.
READ MORE >

Judge dismisses lawsuit against Texas cardiologist

Two hospitals had accused the interventional cardiologist of working with other healthcare providers to interfere with recruitment efforts.

READ MORE >
statue justice legal verdict malpractice case lawsuit scale
Share on Twitter Share on Facebook Share on Linkedin

Judge dismisses lawsuit against Texas cardiologist

Share on Twitter Share on Facebook Share on Linkedin
statue justice legal verdict malpractice case lawsuit scale
Two hospitals had accused the interventional cardiologist of working with other healthcare providers to interfere with recruitment efforts.
READ MORE >

FDA clears first blood test of its kind for Lp(a)

The new blood test from Roche Diagnostics measures Lp(a) in terms of nanomoles per liter (nmol/L) as opposed to milligrams per deciliter (mg/dL).

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

FDA clears first blood test of its kind for Lp(a)

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
The new blood test from Roche Diagnostics measures Lp(a) in terms of nanomoles per liter (nmol/L) as opposed to milligrams per deciliter (mg/dL).
READ MORE >

In Case You Missed It

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 
READ MORE >

FDA regulator examines AI's growing influence in cardiology

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

READ MORE >
Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.
Share on Twitter Share on Facebook Share on Linkedin

FDA regulator examines AI's growing influence in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
READ MORE >

Diabetes reduces survival after SAVR, but not TAVR

"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

READ MORE >
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Share on Twitter Share on Facebook Share on Linkedin

Diabetes reduces survival after SAVR, but not TAVR

Share on Twitter Share on Facebook Share on Linkedin
A TAVR procedure being performed at Northwestern Medicine in Chicago.
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
READ MORE >

In Other News

Automated tracking helps leave no incidental finding behind

Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.  

READ MORE >
A new Harvey L. Neiman Health Policy Institute study found that between 2017 and 2019 the number of non-physician providers (NPPs, which includes nurse practitioners and physician assistants) employed by radiology only practices increased 18%. This increase was associated with more NPPs employed per practice, as well as an 11% increase in the number of practices employing them. 
Share on Twitter Share on Facebook Share on Linkedin

Automated tracking helps leave no incidental finding behind

Share on Twitter Share on Facebook Share on Linkedin
A new Harvey L. Neiman Health Policy Institute study found that between 2017 and 2019 the number of non-physician providers (NPPs, which includes nurse practitioners and physician assistants) employed by radiology only practices increased 18%. This increase was associated with more NPPs employed per practice, as well as an 11% increase in the number of practices employing them. 
Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.  
READ MORE >

Zimmer agrees to buy Paragon 28 for $1.1B

Zimmer Biomet plans to add ankle and foot surgical implants to its portfolio once the deal is finalized and approved by regulators. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Zimmer agrees to buy Paragon 28 for $1.1B

Share on Twitter Share on Facebook Share on Linkedin
Zimmer Biomet plans to add ankle and foot surgical implants to its portfolio once the deal is finalized and approved by regulators. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup